<code id='5C088A6AA6'></code><style id='5C088A6AA6'></style>
    • <acronym id='5C088A6AA6'></acronym>
      <center id='5C088A6AA6'><center id='5C088A6AA6'><tfoot id='5C088A6AA6'></tfoot></center><abbr id='5C088A6AA6'><dir id='5C088A6AA6'><tfoot id='5C088A6AA6'></tfoot><noframes id='5C088A6AA6'>

    • <optgroup id='5C088A6AA6'><strike id='5C088A6AA6'><sup id='5C088A6AA6'></sup></strike><code id='5C088A6AA6'></code></optgroup>
        1. <b id='5C088A6AA6'><label id='5C088A6AA6'><select id='5C088A6AA6'><dt id='5C088A6AA6'><span id='5C088A6AA6'></span></dt></select></label></b><u id='5C088A6AA6'></u>
          <i id='5C088A6AA6'><strike id='5C088A6AA6'><tt id='5C088A6AA6'><pre id='5C088A6AA6'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:92
          Dozens of sickle cells in a whirlpool — coverage from STAT
          Adobe

          Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes. 

          The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

          advertisement

          “We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Why sickle cell disease is getting the first CRISPR treatment
          Why sickle cell disease is getting the first CRISPR treatment

          AdobeNearlyadecadeago,consultantsdeliveredtoRodgerNovakakindofSearscatalogofhumanmalady:200pages,lis

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          CMS should re

          AdobeIn2011,theCentersforMedicareandMedicaidServicescreatedtheannualwellnessvisit(AWV),anewvisittype